GeneDx Holdings Corp.WGS

A genomic diagnostics company that provides whole-genome sequencing and genetic testing services, primarily for pediatric and rare disease patients. It has transitioned from a broader genetic testing provider to a focused rare disease and pediatric genomics leader, with a growing data repository that supports diagnostic yield improvements. Investors track WGS for its revenue growth trajectory and its potential to expand into population screening and pharmaceutical partnerships.